The company, which was bought by Taiwan-based Bora Pharmaceuticals in a $210 million deal last year, is keeping its facility ...
Longtime Minnesota-based generic drugmaker Upsher-Smith Laboratories, which was sold to a Taiwanese firm in 2024, is closing one of its two drug plants in the state and refocusing work here on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results